David Hoang

Q: What is David Hoang's success rate?

David Hoang currently has a success rate of 82.40638341713314.

Q: What is the average return of David Hoang's calls?

Their stock ratings have generated an average return of 40.41512970868787.

Deutsche Bank | Healthcare

David Hoang is an analyst from Deutsche Bank specializing in the Healthcare sector. Ranked #593 out of 4773 analysts, they have issued 16 stock ratings with a success rate of 82.41% and an average return of 40.42%.

With 16 ratings to date, David Hoang is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 82.41% and an average return of 40.42%, highlighting promising potential as their track record develops further.

#593

Out of 4773

Total Ratings

+82.41%

Success Rate

+40.42%

Average Return

Recent Ratings Analysis

ACAD

Buy

Aug 25, 2026

Target

$38.00

Current

$27.83

Performance

-8.96%

David Hoang rated ACAD as Buy on Aug 25, 2026, setting a price target of 38. The stock has underperformed, dropping 8.96% despite the bullish target of 38.

KYMR

Hold

Jul 30, 2026

Target

$120.00

Current

$114.96

Performance

7.43%

On Jul 30, 2026, KYMR was given a Hold rating by David Hoang, with a target price of 120. The stock rallied from 114.96 to 114.96 after the Hold rating, surprising to the upside.

DNLI

Buy

Jul 16, 2026

Target

$35.00

Current

$21.09

Performance

-7.22%

DNLI received a Buy rating from David Hoang on Jul 16, 2026, aiming for 35. The rating hasn’t played out as hoped, with the stock trading 7.22% below expectations.

HRMY

Hold

Jun 30, 2026

Target

$36.00

Current

$41.52

Performance

14.03%

On Jun 30, 2026, David Hoang published a Hold outlook on HRMY, with a target of 36. The Hold call missed some of the bullish momentum as shares advanced toward 36.

SYRE

Buy

Jun 23, 2026

Target

$135.00

Current

$90.60

Performance

-6.65%

David Hoang on Jun 23, 2026 assigned SYRE a Buy rating, with a price target of 135. The call has struggled to gain traction, with shares losing 6.65%.

APGE

Hold

Jun 23, 2026

Target

$135.00

Current

$135.07

Performance

1.65%

On Jun 23, 2026, David Hoang reaffirmed APGE with a Hold rating, targeting 135. The neutral call matched muted market action of 1.65%.

PRAX

Buy

Jun 02, 2026

Target

$374.00

Current

$334.58

Performance

—

PRAX was rated Buy by David Hoang on Jun 02, 2026, with a price objective of 374. The stock is in a wait-and-see zone, leaving the Buy case open-ended.

ATAI

Buy

Mar 27, 2026

Target

$12.00

Current

$7.35

Performance

119.40%

On Mar 27, 2026, David Hoang initiated coverage on ATAI with a Buy rating and target of 12. The stock’s climb of 119.40% since the call highlights the foresight in the rating.

XENE

Buy

Mar 10, 2026

Target

$90.00

Current

$58.65

Performance

-3.23%

David Hoang issued a Buy recommendation for XENE on Mar 10, 2026, price target set at 90. The target of 90 remains in play, though confirmation will depend on future moves.

ALKS

Buy

Nov 13, 2025

Target

$45.00

Current

$45.97

Performance

48.24%

On Nov 13, 2025, ALKS was evaluated by David Hoang, who gave a Buy rating and target of 45. This case illustrates how a timely bullish rating can translate into tangible gains of 48.24%.

SRPT

Sell

Aug 15, 2025

Target

$12.00

Current

$20.45

Performance

-6.24%

David Hoang rated SRPT as Sell on Aug 15, 2025, setting a price target of 12. The Sell call didn’t play out, with shares rallying -6.24% to 20.45.

BHVN

Buy

Feb 11, 2025

Target

$65.00

Current

$12.71

Performance

-70.12%

On Feb 11, 2025, BHVN was given a Buy rating by David Hoang, with a target price of 65. Despite the Buy call, shares fell from 12.71 to 12.71, challenging the optimistic stance.

AVDL

Buy

Feb 11, 2025

Target

$12.00

Current

$21.64

Performance

140.44%

AVDL received a Buy rating from David Hoang on Feb 11, 2025, aiming for 12. Momentum has favored the Buy call, with shares climbing from 21.64 to 21.64, rewarding those who trusted the recommendation.

AXSM

Buy

Feb 11, 2025

Target

$176.00

Current

$220.75

Performance

66.98%

On Feb 11, 2025, David Hoang published a Buy outlook on AXSM, with a target of 176. Shares gained 66.98%, underscoring the accuracy of the bullish outlook toward 176.

NBIX

Hold

Aug 02, 2024

Target

$158.00

Current

$156.22

Performance

2.01%

David Hoang on Aug 02, 2024 assigned NBIX a Neutral rating, with a price target of 158. The Hold stance reflected consolidation, as shares held near 156.22.

LBPH

Buy

Aug 02, 2024

Target

$50.00

Current

$59.98

Performance

82.59%

On Aug 02, 2024, David Hoang reaffirmed LBPH with a Buy rating, targeting 50. The recommendation was supported by strong follow-through as the stock rose from 59.98 to 59.98.

ABOS

Buy

Jul 25, 2024

Target

$7.00

Current

$2.92

Performance

-14.37%

ABOS was rated Buy by David Hoang on Jul 25, 2024, with a price objective of 7. This case shows how bullish projections can fail, with the stock now below 2.92.

Frequency Asked Questions

Who is David Hoang?

David Hoang is an analyst from Deutsche Bank specializing in the Healthcare sector.

What is David Hoang's success rate?

David Hoang currently has a success rate of +82.41%.

How many ratings has David Hoang issued?

David Hoang has issued 16 stock ratings so far.

What is the average return of David Hoang's calls?

Their stock ratings have generated an average return of +40.42%.

What is David Hoang's ranking?

David Hoang is ranked #593 out of 4773 analysts.

What types of ratings does David Hoang give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow David Hoang?

You can follow David Hoang by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by David Hoang?

Their latest rating was a Buy on ACAD issued on 2026-08-25.